16th July 2021
AXA IM: Growth is what you buy, value is what you get
Fortune has favoured the value investor over the past six months or so. The announcement and subsequent rollout of vaccines has led to a sharp outperformance for value stocks since the end of October 2020, with sectors such as banking, energy, mining and tourism & leisure making up for poor performance from the initial impact of COVID-19.

You need to be logged in to comment on this article